PCN33 Indirect Analysis of the Efficacy and Safety of Pemetrexed/Cisplatin Compared With Bevacizumab/Gemcitabine/Cisplatin as First-Line Treatment for Advanced, Non-Squamous Non-Small Cell Lung Cancer and Associated Treatment Costs in the P ...
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.1150
https://www.valueinhealthjournal.com/article/S1098-3015(12)01215-6/fulltext
Title :
PCN33 Indirect Analysis of the Efficacy and Safety of Pemetrexed/Cisplatin Compared With Bevacizumab/Gemcitabine/Cisplatin as First-Line Treatment for Advanced, Non-Squamous Non-Small Cell Lung Cancer and Associated Treatment Costs in the P ...
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)01215-6&doi=10.1016/j.jval.2012.03.1150
First page :
A213
Section Title :
Cancer
Open access? :
No
Section Order :
670